Previous studies by Gao et al. (2017) showed that IL-33 attenuated cerebral edema, inhibited neuronal cell death, and improved neurological impairment by inhibiting the expression of proinflammatory cytokines IL-1β and TNF-α in a model of cerebral hemorrhage. Here, IL1B is linked to brain edema.